No Data
No Data
Kaisheng New Materials: Report for the first quarter of 2025
Kaisheng New Materials (301069.SZ) released its first-quarter performance, with a net income of 30.6702 million yuan, an increase of 19.35%.
Kai Sheng New Materials (301069.SZ) released its first quarter report for 2025, with revenue of 2.69...
Shandong Kaisheng New Materials Co.,Ltd.'s (SZSE:301069) Market Cap Surged CN¥408m Last Week, Public Companies Who Have a Lot Riding on the Company Were Rewarded
Kaisheng New Materials (301069.SZ): Currently able to stably supply customers with high-purity Battery-grade thionyl chloride products.
On March 31, Gelonghui reported that Kaisheng New Materials (301069.SZ) stated in a recent investor relations event that the company can currently stably supply customers with high-purity battery-grade thionyl chloride products, mainly used for electrolytes in lithium-ion batteries and for the synthesis of LiFSI products. At the same time, the company has been closely monitoring the development trends in the Solid State Battery/Half Solid State Battery Industry, and based on the current known technological pathways, LiFSI produced from battery-grade thionyl chloride can be used in half-solid state batteries.
Kaisheng New Materials (301069.SZ): PEKK products have been applied by end customers in fields such as general profiles, spraying, New energy Fund Autos, Military Industry, and Aviation.
On March 31, Gelonghui reported that Kaisheng New Materials (301069.SZ) stated in a recent investor relations activity that so far, the company's PEKK products have been applied by end customers in fields such as general profiles, coatings, New energy Fund, Military Industry, and Aviation. Meanwhile, the company is closely monitoring the market demand for Lightweight specialty materials in the fields of electronic information (Semiconductors), rehabilitation medical instruments, and Siasun Robot&Automation.
Kaisheng New Materials (301069.SZ): has not yet directly laid out the Business in the field of synthetic biology.
On March 31, Gelonghui reported that Kaisheng New Materials (301069.SZ) has recently indicated in investor relations activities that the company has not yet directly engaged in the business of synthetic biology.